Back to Agenda
Welcome to Day Two and Session 5: Fireside Chat: Implementing the Plausible Mechanism Pathway: From Concept to Clinic
Session Chair(s)
Hobart Rogers, PHARMD, PHD
Pharmacologist, CDER
FDA, United States
Dan Swerdlow, MD, PHD
Senior Director, Early Clinical Development
GSK, United Kingdom
Welcome to Day Two and Session 5: Fireside Chat: Implementing the Plausible Mechanism Pathway: From Concept to Clinic
Have an account?
